Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurjen Tel

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Immunology|March 18, 2011
DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cellsJurjen Tel, Daniel Benitez-Ribas, Sander Hoosemans, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2010
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapyGerty Schreibelt, Jurjen Tel, Kwinten H E W J Sliepen, et al.
Frontiers in Immunology|April 10, 2024
Unraveling IFN-I response dynamics and TNF crosstalk in the pathophysiology of systemic lupus erythematosusLaura C Van Eyndhoven, Eleni Chouri, Catarina I Matos, et al.
Oncoimmunology|March 5, 2016
Long-lasting multifunctional CD8<sup>+</sup> T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccinationFlorian Wimmers, Erik H J G Aarntzen, Tjitske Duiveman-deBoer, et al.
Frontiers in Immunology|December 15, 2018
Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and DeliveryJorieke Weiden, Dion Voerman, Yusuf Dölen, et al.
Oncoimmunology|March 5, 2016
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responsesYusuf Dölen, Martin Kreutz, Uzi Gileadi, et al.
ACS Omega|April 11, 2017
Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency EffectRoel Hammink, Subhra Mandal, Loek J Eggermont, et al.
Biomacromolecules|September 29, 2018
Development of Morphologically Discrete PEG-PDLLA Nanotubes for Precision NanomedicineAnnelies C Wauters, Imke A B Pijpers, Alexander F Mason, et al.
Advanced Biology|December 14, 2022
Single-Cell Profiling Reveals Functional Heterogeneity and Serial Killing in Human Peripheral and Ex Vivo-Generated CD34+ Progenitor-Derived Natural Killer CellsNikita Subedi, Liesbeth Petronella Verhagen, Paul de Jonge, et al.
Plos One|January 4, 2013
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potentialSébastien Anguille, Eva Lion, Jurjen Tel, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Immunology|March 18, 2011
DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cellsJurjen Tel, Daniel Benitez-Ribas, Sander Hoosemans, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2010
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapyGerty Schreibelt, Jurjen Tel, Kwinten H E W J Sliepen, et al.
Frontiers in Immunology|April 10, 2024
Unraveling IFN-I response dynamics and TNF crosstalk in the pathophysiology of systemic lupus erythematosusLaura C Van Eyndhoven, Eleni Chouri, Catarina I Matos, et al.
Oncoimmunology|March 5, 2016
Long-lasting multifunctional CD8<sup>+</sup> T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccinationFlorian Wimmers, Erik H J G Aarntzen, Tjitske Duiveman-deBoer, et al.
Frontiers in Immunology|December 15, 2018
Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and DeliveryJorieke Weiden, Dion Voerman, Yusuf Dölen, et al.
Oncoimmunology|March 5, 2016
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responsesYusuf Dölen, Martin Kreutz, Uzi Gileadi, et al.
ACS Omega|April 11, 2017
Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency EffectRoel Hammink, Subhra Mandal, Loek J Eggermont, et al.
Biomacromolecules|September 29, 2018
Development of Morphologically Discrete PEG-PDLLA Nanotubes for Precision NanomedicineAnnelies C Wauters, Imke A B Pijpers, Alexander F Mason, et al.
Advanced Biology|December 14, 2022
Single-Cell Profiling Reveals Functional Heterogeneity and Serial Killing in Human Peripheral and Ex Vivo-Generated CD34+ Progenitor-Derived Natural Killer CellsNikita Subedi, Liesbeth Petronella Verhagen, Paul de Jonge, et al.
Plos One|January 4, 2013
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potentialSébastien Anguille, Eva Lion, Jurjen Tel, et al.
Pageof 7